TrialGastroenterology2011

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

Jasmohan S Bajaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.